The Federal Trade Commission has announced a settlement with an auto dealership group over alleged price-transparency issues, underscoring that dealer advertising, pricing disclosures, and add-on fee practices remain a live enforcement priority. Even without a headline-grabbing court opinion attached, the matter is important: it shows the agency continuing to police how vehicle prices and fees are presented to consumers, particularly where advertised prices may not clearly reflect the actual amount a buyer is expected to pay.

For auto retailers and their counsel, the takeaway is straightforward.

The Federal Trade Commission has issued warning letters to 24 of the nation’s largest healthcare services companies, putting major hospital and health-system operators on notice that patient pricing practices remain a live consumer-protection priority. Although the agency has not filed an enforcement action, the letters are legally significant: they serve as a public signal that the FTC is scrutinizing whether providers’ pricing disclosures, estimates, and patient-facing cost information could mislead consumers.

The message from FTC leadership is straightforward.